Aakaar Medical Technologies IPO is all set to hit the capital markets. The IPO will be open for subscription from June 20 to June 24, 2025. It is a 100% fresh issue of ₹27.00 crores, comprising of 37.50 lakh equity shares. The price band is set between ₹68 and ₹72 per share, and the listing will happen on the NSE SME platform.
Aakaar Medical Technologies is a Mumbai-based company established in 2013 and is well known for offering a range of cosmetic and aesthetic medical products, mainly to dermatologists, plastic surgeons, and aesthetic professionals. The company offers its own branded products, as well as devices imported from countries like South Korea, Spain, Italy, and Austria.
Over the years, Aakaar Medical Technologies has built a strong network across several Indian states and boasts a dedicated sales and service team comprising 90 members.
Aakaar Medical Technologies IPO Details
| IPO Name | Aakaar Medical Technologies |
| IPO Open and Close Date | June 20, 2025 to June 24, 2025 |
| Issue Price Band | ₹68 to ₹72 per share |
| Lot Size | 1,600 Shares |
| Listing At | NSE SME |
| Allotment Date | June 25, 2025 |
| Listing Date | June 27, 2025 |
| Retail Investors Minimum Lot & Amount | 1 lot & ₹1,15,200 |
| Retail Investors Maximum Lot & Amount | 1 lot & ₹1,15,200 |
| HNIs Minimum Lot & Amount | 2 lots & ₹2,30,400 |
Aakaar Medical Technologies IPO -FAQs
1. What are the IPO dates for Aakaar medical Technilogies IPO?
The IPO opens on June 20, 2025, and closes on June 24, 2025. Allotment will be finalized by June 25, 2025, and listing is expected on June 27, 2025.
2. What is the lot size and minimum investment for retail and HNIs?
For retail investors, the minimum lot size is 1, comprising 1600 shares, amounting to ₹1,15,200. For HNIs, the minimum lot size is 2, and the investment amount is ₹2,30,400.
3. Where will the shares be listed?
The shares will be listed on the NSE SME platform.
4. What is the issue size and structure?
This is a fresh issue of 37.50 lakh shares, amounting to ₹27 crore.
5. What does Aakaar Medical Technologies do?
They are a medical aesthetic company dealing in a wide range of aesthetics & specialized cosmetic products & devices. The company primarily provides the products & devices to dermatologists, plastic surgeons, and aesthetic physicians who then sell these products to their
end consumers as well as use certain device consumables as part of their treatments.
6. What will the company use the IPO proceeds for?
Out of the ₹27 crore raised, ₹20.35 crore will go towards working capital needs, and the rest for general corporate purposes.
7. How has the company performed financially?
Aakaar Medical has shown consistent growth:
-
FY 2023: Revenue ₹32.88 Cr | PAT ₹2.15 Cr
-
FY 2024: Revenue ₹46.27 Cr | PAT ₹2.87 Cr
-
FY 2025 (till Mar): Revenue ₹61.76 Cr | PAT ₹6.04 Cr
8. What are the key strengths of the company?
-
Wide range of skincare and aesthetic products
-
Presence in both domestic and imported brands
-
Established customer base in the medical aesthetics segment
-
Experienced promoters and a skilled technical team
-
Consignment-based sales model ensures deeper market penetration
9. Who is the registrar for the IPO?
Bigshare Services Pvt Ltd is the registrar for the issue.
10. What are the Key Risks in Aakaar Medical Technologies IPO?
Aakaar Medical Technologies faces several operational and business risks, including.
a. Heavy dependence on imports: A significant portion of the products are imported from countries like South Korea, Spain, Italy, and Austria. Any distribution in the supply chains may impact business operations
b. Geographic concentration: A large pert of the company’s revenue comes from Maharashtra and Karnataka, any adverse events in this regions will impact the revenue flow.
c. Reliance on third-party partners: The company depends on third-party manufacturers and a single distributor, any break-down in this relationship may disrupt supply and delivery.
d. Delays in Collections: Any delays in cash collections from the clients can lead to cash flow challenges and increase credit-risk.
11. What is the Sector Outlook for Aakaar Medical Technologies?
a. Growing demand for non-invasive treatments: There is an increasing demand for aesthetic and cosmetic treatments, like, laser hair removal, skin rejuvenation, hair regrowth, and anti-aging products.
b. Favorable demographics: Young population, higher disposable incomes, and rising urbanization are fueling demand for cosmetic treatments.
c. Appearance Awareness: Greater appearance awareness among millennials and Gen-Z is driving growth for aesthetic procedures.
d. Pan-India market expansion: Demand is no longer restricted just to metros; tier-2 and tier-3 cities are emerging as new growth centers.
e. Global trends influencing the Indian market: India is aligning with global trends in beauty and wellness, thereby encouraging cutting-edge devices and treatments.
12. What is the current GMP of the IPO?
The current GMP is ₹0.
Aakaar Medical Technologies IPO – Conclusion
Aakaar Medical Technologies Limited’s IPO offers investors an interesting opportunity in the fast-growing aesthetic and cosmetic medical device sector. The company has a strong product portfolio, achieved consistent revenue growth, and has a pan-India footprint.
However, with any investment, the investors should evaluate the risk, assess the company’s financials and market conditions before subscribing to the IPO.